Procter & Gamble reported second‐quarter adjusted earnings of $1.88 per share, exceeding the consensus estimate of $1.86, on net sales of $22.2 billion, up 1 percent year‐over‐year. Organic sales were unchanged as a 1 percent price increase was offset by a 1 percent volume decline. By segment, Beauty organic sales rose 4 percent, driven by premium Skin Care pricing in Greater China and innovation-led volume growth in Hair Care. Health Care grew 3 percent on favorable mix in Oral Care and Personal Health, while Grooming held flat as higher pricing offset unit declines. Fabric & Home Care was flat, and Baby, Feminine & Family Care declined 4 percent, weighed down by volume weakness in baby and family care.

Management lowered its GAAP earnings guidance for fiscal 2026 to a range of $6.58–$6.90 per share from $6.71–$7.09, reflecting higher restructuring charges. Core earnings per share guidance remains in-line to up 4 percent versus last year’s $6.83. Organic sales are forecast flat to up 4 percent, with commodity costs expected to be neutral and foreign-exchange movements contributing approximately one percentage point to all-in sales growth. Tariff impacts are projected to total roughly $400 million after tax, while interest and tax headwinds amount to $0.19 per share.

To counter flat global volumes, P&G is accelerating premium innovation, notably with its Pampers Prestige diaper line in China. These silk‐fiber diapers have driven double-digit organic sales growth and a 3 percent market share gain in Greater China over the past 18 months, helping the baby care division achieve 20 percent organic sales growth in that region despite a record low birth rate. In contrast, North American organic sales fell 2 percent in the quarter, underscoring the company’s reliance on innovation to sustain growth in mature markets.